Medtronic plc Stock News

Ari Wald, managing director and head of technical analysis at Oppenheimer, joins 'The Exchange' to discuss Medtronic, Agilent Technologies, and Trip.com.

Medtronic (MDT) receives the FDA approval for Symplicity blood pressure procedure for the treatment of hypertension.

The U.S. Food and Drug Administration on Friday approved the use of Medtronic's treatment device in a surgery called renal denervation in patients whose high blood pressure cannot be controlled by dru

Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal second-quarter performance.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Beyond analysts' top -and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarte

Amidst the uncertainty, savvy investors recognize that market downturns potentially pave the way for future prosperity. However, the quest for long-term stocks to buy soon remains fraught with challen

While sometimes overshadowed by stocks in the mega-cap ($200 billion market cap and higher) stocks category, large-cap stocks (or stocks with a market cap between $10 billion and $200 billion) can oft

Medtronic's growth rate has been underwhelming in recent years. Growth is a priority now and Medtronic is selling off majority stake in slower-growing areas of its business.

One of my favorite investment strategies when seeking forever stocks is to look to past trends that turned stale. Think of some of the hottest sectors in the past five years that saw massive investor

If you're a dividend investor, there is nothing more attractive than dividend aristocrats, those S&P 500 companies that have increased their annual dividend payment for 25 consecutive years or more. 

Medtronic (MDT) closed the most recent trading day at $72.08, moving +1.98% from the previous trading session.

Investing in long-term stocks as a 30-year-old is a tricky proposition. On the one hand, you've likely got something close enough to a disposable income that you can afford to sock away extra cash int

Finding long-term stocks isn't always easy. Avoiding meme stock mania, FOMO, and value traps is difficult in any economy but particularly troublesome today.